Cargando…
Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus: Current Status and Future Direction
Pulmonary arterial hypertension (PAH) is commonly associated with connective tissue diseases (CTDs) including systemic sclerosis and systemic lupus erythematosus (SLE). The prevalence of PAH in SLE is estimated to be 0.5% to 17.5%. The pathophysiology of PAH involves multiple mechanisms from vasculi...
Autor principal: | Dhala, Atiya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3318206/ https://www.ncbi.nlm.nih.gov/pubmed/22489252 http://dx.doi.org/10.1155/2012/854941 |
Ejemplares similares
-
Systemic Lupus Erythematosus and Pulmonary Hypertension
por: Parperis, Konstantinos, et al.
Publicado: (2023) -
Cutaneous Lupus Erythematosus: Current and Future Pathogenesis-Directed Therapies
por: Little, Alicia J., et al.
Publicado: (2020) -
Systemic lupus erythematosus and pulmonary arterial hypertension: links, risks, and management strategies
por: Tselios, Konstantinos, et al.
Publicado: (2016) -
Asymptomatic Pulmonary Hypertension in Systemic Lupus Erythematosus
por: Kamel, Shereen R., et al.
Publicado: (2011) -
Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives
por: Magro-Checa, César, et al.
Publicado: (2016)